Insulet Price to Book Ratio 2012-2025 | PODD
Historical price to book ratio values for Insulet (PODD) over the last 10 years. The current price to book ratio for Insulet as of March 05, 2026 is 12.34.
| Insulet Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-03-05 | 240.94 | 12.25 | |
| 2025-09-30 | 308.73 | $19.68 | 15.69 |
| 2025-06-30 | 314.18 | $20.78 | 15.12 |
| 2025-03-31 | 262.61 | $18.91 | 13.89 |
| 2024-12-31 | 261.07 | $17.31 | 15.09 |
| 2024-09-30 | 232.75 | $15.94 | 14.60 |
| 2024-06-30 | 201.80 | $14.24 | 14.17 |
| 2024-03-31 | 171.40 | $11.29 | 15.18 |
| 2023-12-31 | 216.98 | $10.48 | 20.70 |
| 2023-09-30 | 159.49 | $8.70 | 18.33 |
| 2023-06-30 | 288.34 | $7.94 | 36.34 |
| 2023-03-31 | 318.96 | $7.21 | 44.21 |
| 2022-12-31 | 294.39 | $6.85 | 42.95 |
| 2022-09-30 | 229.40 | $6.16 | 37.21 |
| 2022-06-30 | 217.94 | $6.09 | 35.80 |
| 2022-03-31 | 266.39 | $6.44 | 41.34 |
| 2021-12-31 | 266.07 | $8.04 | 33.09 |
| 2021-09-30 | 284.23 | $7.22 | 39.34 |
| 2021-06-30 | 274.51 | $6.69 | 41.02 |
| 2021-03-31 | 260.92 | $8.84 | 29.52 |
| 2020-12-31 | 255.63 | $9.14 | 27.96 |
| 2020-09-30 | 236.59 | $9.03 | 26.19 |
| 2020-06-30 | 194.26 | $8.59 | 22.62 |
| 2020-03-31 | 165.68 | $0.94 | 177.08 |
| 2019-12-31 | 171.20 | $1.21 | 141.39 |
| 2019-09-30 | 164.93 | $2.44 | 67.68 |
| 2019-06-30 | 119.38 | $4.15 | 28.75 |
| 2019-03-31 | 95.09 | $3.75 | 25.36 |
| 2018-12-31 | 79.32 | $3.58 | 22.14 |
| 2018-09-30 | 105.95 | $3.35 | 31.62 |
| 2018-06-30 | 85.70 | $3.04 | 28.21 |
| 2018-03-31 | 86.68 | $2.90 | 29.84 |
| 2017-12-31 | 69.00 | $2.72 | 25.39 |
| 2017-09-30 | 55.08 | $1.28 | 43.14 |
| 2017-06-30 | 51.31 | $1.12 | 46.01 |
| 2017-03-31 | 43.09 | $1.10 | 39.25 |
| 2016-12-31 | 37.68 | $1.10 | 34.28 |
| 2016-09-30 | 40.94 | $1.13 | 36.11 |
| 2016-06-30 | 30.24 | $0.48 | 63.08 |
| 2016-03-31 | 33.16 | $0.46 | 71.74 |
| 2015-12-31 | 37.81 | $0.60 | 63.24 |
| 2015-09-30 | 25.91 | $0.97 | 26.75 |
| 2015-06-30 | 30.99 | $1.24 | 25.09 |
| 2015-03-31 | 33.35 | $1.42 | 23.42 |
| 2014-12-31 | 46.06 | $1.49 | 30.93 |
| 2014-09-30 | 36.85 | $1.43 | 25.70 |
| 2014-06-30 | 39.67 | $1.40 | 28.27 |
| 2014-03-31 | 47.42 | $2.22 | 21.39 |
| 2013-12-31 | 37.10 | $2.27 | 16.34 |
| 2013-09-30 | 36.24 | $2.23 | 16.27 |
| 2013-06-30 | 31.41 | $2.55 | 12.34 |
| 2013-03-31 | 25.86 | $2.43 | 10.64 |
| 2012-12-31 | 21.22 | $0.91 | 23.23 |
| 2012-09-30 | 21.58 | $1.05 | 20.58 |
| 2012-06-30 | 21.37 | $1.23 | 17.33 |
| 2012-03-31 | 19.14 | $1.47 | 13.01 |
| 2011-12-31 | 18.83 | $1.74 | 10.81 |
| 2011-09-30 | 15.26 | $1.76 | 8.67 |
| 2011-06-30 | 22.17 | $1.99 | 11.13 |
| 2011-03-31 | 20.62 | $1.30 | 15.81 |
| 2010-12-31 | 15.50 | $1.46 | 10.63 |
| 2010-09-30 | 14.14 | $0.83 | 16.95 |
| 2010-06-30 | 15.05 | $1.10 | 13.73 |
| 2010-03-31 | 15.09 | $1.08 | 13.99 |
| 2009-12-31 | 14.28 | $1.64 | 8.71 |
| 2009-09-30 | 11.23 | $0.01 | 1145.92 |
| 2009-06-30 | 7.70 | $-0.12 | -61.90 |
| 2009-03-31 | 4.10 | $0.56 | 7.38 |
| 2008-12-31 | 7.72 | $1.01 | 7.63 |
| 2008-09-30 | 13.92 | $1.14 | 12.20 |
| 2008-06-30 | 15.73 | $1.85 | 8.50 |
| 2008-03-31 | 14.40 | $2.67 | 5.38 |
| 2007-12-31 | 23.48 | $3.39 | 6.93 |
| 2007-09-30 | 21.75 | $3.64 | 5.97 |
| 2007-06-30 | 14.20 | $4.16 | 3.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.076B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |